Allianz Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,400	Closed	-$316K	–	2149
2024 Q1	$316K	Hold	15,400	–	–	﹤0.01%	1733
2023 Q4	$330K	Buy	15,400 +700	+5%	+$13.9K	﹤0.01%	1955
2023 Q3	$303K	Hold	14,700	–	–	﹤0.01%	2058
2023 Q2	$434K	Buy	14,700 +3,400	+30%	+$95.6K	﹤0.01%	1772
2023 Q1	$260K	Hold	11,300	–	–	﹤0.01%	2012
2022 Q4	$314K	Hold	11,300	–	–	﹤0.01%	1807
2022 Q3	$347K	Sell	11,300 -3,520	-24%	-$114K	﹤0.01%	1583
2022 Q2	$436K	Sell	14,820 -3,000	-17%	-$78.6K	﹤0.01%	1925
2022 Q1	$574K	Sell	17,820 -18,325	-51%	-$631K	﹤0.01%	2068
2021 Q4	$1.61M	Buy	36,145 +17,410	+93%	+$825K	﹤0.01%	1699
2021 Q3	$945K	Sell	18,735 -4,720	-20%	-$266K	﹤0.01%	1958
2021 Q2	$1.84M	Hold	23,455	–	–	﹤0.01%	1496
2021 Q1	$1.34M	Sell	23,455 -8,805	-27%	-$589K	﹤0.01%	1542
2020 Q4	$2.7M	Buy	+32,260	New	+$1.95M	﹤0.01%	1230
2020 Q1	–	Sell	-33,154	Closed	-$577K	–	2534
2019 Q4	$577K	Sell	33,154 -28,062	-46%	-$467K	﹤0.01%	2393
2019 Q3	$952K	Sell	61,216 -45	-0.1%	-$860	﹤0.01%	2150
2019 Q2	$1.27M	Sell	61,261 -38,561	-39%	-$864K	﹤0.01%	2057
2019 Q1	$2.32M	Buy	99,822 +8,618	+9%	+$180K	﹤0.01%	1800
2018 Q4	$1.86M	Sell	91,204 -132,076	-59%	-$2.4M	﹤0.01%	1794
2018 Q3	$4.85M	Sell	223,280 -13,510	-6%	-$223K	0.01%	1568
2018 Q2	$3.61M	Buy	236,790 +500	+0.2%	+$9.42K	﹤0.01%	1684
2018 Q1	$4.65M	Buy	236,290 +36,745	+18%	+$755K	0.01%	1562
2017 Q4	$3.12M	Buy	+199,545	New	+$3.59M	﹤0.01%	1826